M. Sastre-y-Hernández

Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach.

A. Bertolino, V. Rapisarda, D. Crippa, 1988, International clinical psychopharmacology.

Rolipram versus nortriptyline in gerontopsychiatric inpatients with major depression

K. Behnke, A. Korner, A. Geisler, 1992 .

Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports

R. Horowski, M. Sastre-y-Hernández, 1985 .

Results of a Phase II Study of the Antidepressant Effect of Rolipram

B. Pflug, M. Sastre-y-Hernández, E. Zeller, 1984, Pharmacopsychiatry.

A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder.

W. Fleischhacker, H. Hinterhuber, P. Berner, 1992, Neuropsychobiology.

Rolipram in major depression: results of a double-blind comparative study with amitriptyline

K. Fichte, M. Sastre-y-Hernández, U. Meya, 1988 .

Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine

N. Geyer, W. Schöny, K. Fellerer, 1989, Pharmacopsychiatry.

Is Phosphodiesterase inhibition a new mechanism of antidepressant action?

G. Plomteux, H. Wachtel, M. Sastre-y-Hernández, 1988, European archives of psychiatry and neurological sciences.

Use of lormetazepam (noctamid®) as a hypnotic in depressed patients: double-blind study on interactions with anti-depressant medication

R. Horowski, K. Fichte, M. Sastre-y-Hernández, 1985 .